Handelsbanken Fonder’s Myriad Genetics MYGN Stock Holding History

Handelsbanken Fonder’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30,788	Closed	-$273K	–	1549
2025 Q1	$273K	Hold	30,788	–	–	﹤0.01%	1433
2024 Q4	$422K	Buy	30,788 +3,500	+13%	+$64.6K	﹤0.01%	1353
2024 Q3	$747K	Buy	27,288 +3,100	+13%	+$83.9K	﹤0.01%	1066
2024 Q2	$592K	Buy	24,188 +2,000	+9%	+$43.9K	﹤0.01%	1076
2024 Q1	$473K	Buy	22,188 +4,900	+28%	+$105K	﹤0.01%	1189
2023 Q4	$331K	Buy	17,288 +2,800	+19%	+$48.4K	﹤0.01%	1343
2023 Q3	$232K	Hold	14,488	–	–	﹤0.01%	1404
2023 Q2	$336K	Hold	14,488	–	–	﹤0.01%	1288
2023 Q1	$337K	Hold	14,488	–	–	﹤0.01%	1224
2022 Q4	$210K	Hold	14,488	–	–	﹤0.01%	1414
2022 Q3	$276K	Hold	14,488	–	–	﹤0.01%	1291
2022 Q2	$263K	Hold	14,488	–	–	﹤0.01%	1400
2022 Q1	$365K	Sell	14,488 -3,600	-20%	-$92.1K	﹤0.01%	1405
2021 Q4	$499K	Sell	18,088 -800	-4%	-$23.2K	﹤0.01%	1341
2021 Q3	$610K	Hold	18,888	–	–	﹤0.01%	1219
2021 Q2	$578K	Buy	18,888 +6,900	+58%	+$199K	﹤0.01%	1273
2021 Q1	$365K	Hold	11,988	–	–	﹤0.01%	1360
2020 Q4	$237K	Hold	11,988	–	–	﹤0.01%	1480
2020 Q3	$156K	Hold	11,988	–	–	﹤0.01%	1421
2020 Q2	$136K	Buy	+11,988	New	+$170K	﹤0.01%	1416

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Handelsbanken Fonder's MYGN Position: Q2 2025 in Review

Handelsbanken Fonder sold out of Myriad Genetics (MYGN) in Q2 2025, closing a stake of 30,788 shares — an estimated $273K sold.

Handelsbanken Fonder first reported a position in MYGN in Q2 2020 and held it in 20 quarters. The position peaked at $747K in Q3 2024. 221 funds tracked by Wall St. Rank hold MYGN as of Q2 2025.

Handelsbanken Fonder reported no remaining Myriad Genetics position as of Q2 2025 after selling out during the quarter.
Handelsbanken Fonder sold 30,788 Myriad Genetics shares in Q2 2025, an estimated $273K.
Handelsbanken Fonder first reported a position in Myriad Genetics in Q2 2020 and held it in 20 quarters.
Handelsbanken Fonder's Myriad Genetics position peaked at $747K in Q3 2024.
221 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2025.

Based on Handelsbanken Fonder's 13F filing for Q2 2025, filed 12 Aug 2025.